“COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs. ” (2020) Translation: The University of Toledo Journal of Medical Sciences, 7, pp. 1–5. doi:10.46570/utjms.vol7-2020-361.